Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia/U.S. Free Trade Deal Includes Ban On Rx Reimportation

Executive Summary

The U.S./Australia free trade agreement contains a provision barring reimportation of prescription drugs between the two countries

You may also be interested in...



Global Price Controls Elimination May Not Affect U.S. Rx Costs – Economist

Eliminating pharmaceutical price controls in foreign countries would result in more innovation, but not necessarily lower prices for U.S. consumers, American Enterprise Institute economist Kevin Hassett said during an International Trade Administration meeting Aug. 3

Global Price Controls Elimination May Not Affect U.S. Rx Costs – Economist

Eliminating pharmaceutical price controls in foreign countries would result in more innovation, but not necessarily lower prices for U.S. consumers, American Enterprise Institute economist Kevin Hassett said during an International Trade Administration meeting Aug. 3

U.S.-Australia Trade Pact Lacks Language Banning Drug Exportation

Language prohibiting Australia's export of certain drugs to the U.S. was stricken from a bilateral free trade agreement because it was "unnecessary," Assistant U.S. Trade Rep. Ralph Ives said March 12

Related Content

UsernamePublicRestriction

Register

LL1133833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel